Quantum Biopharma (QNTM) Change in Receivables (2020 - 2026)
Quantum Biopharma (QNTM) reported Change in Receivables of $22529.0 for Q1 2026, down 77.34% on a YoY basis from $99417.0 in Q1 2025, and up 122.6% sequentially from -$99701.0 in Q4 2025.
Quantum Biopharma (QNTM) Change in Receivables (2020 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Change in Receivables data on file, last reported at $22529.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 77.34% year-over-year to $22529.0; the trailing twelve-month figure through Mar 2026 stood at $119789.0 (up 210.21% YoY), and the FY2025 full-year result was $196677.0, up 234.79% from the prior year.
- Change in Receivables improved to $22529.0 in Q1 2026, from -$99701.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $626939.0 in Q3 2022 to a low of -$532562.0 in Q2 2022.
- A 5-year average of $26356.0 and a median of $56024.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables plunged 1758.42% in 2024 and soared 762.77% in 2025, its largest moves.
- Tracing QNTM's Change in Receivables over 5 years: stood at -$49813.0 in 2022, then soared by 70.78% to -$14554.0 in 2023, then sank by 1758.42% to -$270474.0 in 2024, then soared by 63.14% to -$99701.0 in 2025, then surged by 122.6% to $22529.0 in 2026.
- Business Quant data shows QNTM's Change in Receivables at $22529.0 in Q1 2026, -$99701.0 in Q4 2025, and $114898.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | 22,529.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,529.00 |
| Mar 31, 2026 | 22,529.00 |
| Dec 31, 2025 | -99,701.00 |
| Dec 31, 2025 | -99,701.00 |
| Sep 30, 2025 | 114,898.00 |
| Sep 30, 2025 | 114,898.00 |
| Jun 30, 2025 | 82,063.00 |
| Jun 30, 2025 | 82,063.00 |
| Mar 31, 2025 | 99,417.00 |
| Mar 31, 2025 | 99,417.00 |
| Dec 31, 2024 | -270,474.00 |
| Dec 31, 2024 | -270,474.00 |
| Sep 30, 2024 | -17,336.00 |
| Sep 30, 2024 | -17,336.00 |
| Jun 30, 2024 | 79,700.00 |
| Jun 30, 2024 | 79,700.00 |
| Mar 31, 2024 | 62,196.00 |
| Mar 31, 2024 | 62,196.00 |
| Dec 31, 2023 | -14,554.00 |
| Dec 31, 2023 | -14,554.00 |